Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 4, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2028

Conditions
Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Trial Locations (5)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

14642

RECRUITING

The University of Rochester Medical Center, Rochester

38105

RECRUITING

St. Jude Children's Research Hospital, Memphis

80045

RECRUITING

University of Colorado Hospital, Aurora

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER